← Back to all trials
Not Yet Recruiting
NCT05693675
Postoperative Oral Methadone After Major Spine Surgery; Safety, Feasibility and Efficacy in Prevention of Progression to Chronic Opioid Usage at 3 Months
Conditions: Spine Surgery
Sex: All
Ages: 18 Years – 70 Years
Phase: PHASE2, PHASE3
Enrollment: 30
Sponsor: The University of Texas Health Science Center, Houston
Location: United States
Summary
The purpose of this study is to evaluate the feasibility and safety of a clinical protocol based on the administration of intraoperative intravenous methadone followed by a short regimen of oral/IV (if the patient is not able to take oral) methadone following spine surgery and to evaluate if methadone decreases persistent opioid usage at 3 months in comparison to placebo.
Eligibility Criteria
Inclusion Criteria:Adults undergoing multilevel complex lumbar and/or thoracic spine fusion surgery, including revision surgeriesExclusion Criteria:BMI greater than 40
Source: ClinicalTrials.gov (NCT05693675). StuddyBuddy aggregates publicly available trial information.
